Inscrição na biblioteca: Guest
Critical Reviews™ in Oncogenesis

Publicou 4 edições por ano

ISSN Imprimir: 0893-9675

ISSN On-line: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Nanoparticle Drug Formulations for Cancer Diagnosis and Treatment

Volume 19, Edição 3-4, 2014, pp. 223-245
DOI: 10.1615/CritRevOncog.2014011563
Get accessGet access

RESUMO

Over the past ten years, more than a billion dollars in U.S. government funding has been awarded to the development of nanomaterials for clinical diagnosis and therapy. In this article we will focus on one subset of nanotechnology: nanoparticle formulations of drugs intended to diagnose or treat cancer. Several nanoparticle drug preparations are now in widespread clinical use, and dozens are in the pipeline. In some cases the nanoparticles are simply passive drug carriers or contrast agents; in others, the nanoparticles have active therapeutic properties. Cancer, particularly solid tumors, is one of nanotechnology's key targets. The specific challenges involved in cancer treatment are those addressed by multifunctional materials, in particular, inaccessibility, widespread metastasis, low oxygen concentrations, and resistance to drugs and radiation. Nonetheless, major barriers still remain to effective nanoparticle design and approval.

CITADO POR
  1. Schill Jurgen, Schenning Albertus P. H. J., Brunsveld Luc, Self-Assembled Fluorescent Nanoparticles from π-Conjugated Small Molecules: En Route to Biological Applications, Macromolecular Rapid Communications, 36, 14, 2015. Crossref

  2. Mekaru Harutaka, Lu Jie, Tamanoi Fuyuhiko, Development of mesoporous silica-based nanoparticles with controlled release capability for cancer therapy, Advanced Drug Delivery Reviews, 95, 2015. Crossref

  3. Siafaka Panoraia, Üstündağ Okur Neslihan, Karavas Evangelos, Bikiaris Dimitrios, Surface Modified Multifunctional and Stimuli Responsive Nanoparticles for Drug Targeting: Current Status and Uses, International Journal of Molecular Sciences, 17, 9, 2016. Crossref

  4. Enrico Catalano, Magnetic Nanomaterial-based Anticancer Therapy, in Advanced Magnetic and Optical Materials, 2016. Crossref

  5. Zhang Yi-Nan, Poon Wilson, Tavares Anthony J., McGilvray Ian D., Chan Warren C.W., Nanoparticle–liver interactions: Cellular uptake and hepatobiliary elimination, Journal of Controlled Release, 240, 2016. Crossref

  6. Singh Yuvraj, Pawar Vivek Kumar, Meher Jaya Gopal, Raval Kavit, Kumar Animesh, Shrivastava Richa, Bhadauria Smrati, Chourasia Manish K., Targeting tumor associated macrophages (TAMs) via nanocarriers, Journal of Controlled Release, 254, 2017. Crossref

  7. Nguyen Hiep X., Targeted Delivery of Surface-Modified Nanoparticles: Modulation of Inflammation for Acute Lung Injury, in Surface Modification of Nanoparticles for Targeted Drug Delivery, 2019. Crossref

  8. Fonseca-Santos Bruno, da Silva Patrícia Bento, Eloy Josimar O., Chorilli Marlus, Nanocarriers for the Diagnosis and Treatment of Cancer, in Nanocarriers for Drug Delivery, 2021. Crossref

  9. Li Jianfeng, Yang Huiying, Zhang Yujie, Jiang Xutao, Guo Yubo, An Sai, Ma Haojun, He Xi, Jiang Chen, Choline Derivate-Modified Doxorubicin Loaded Micelle for Glioma Therapy, ACS Applied Materials & Interfaces, 7, 38, 2015. Crossref

  10. Drude Natascha, Singh Smriti, Winz Oliver H., Möller Martin, Mottaghy Felix M., Morgenroth Agnieszka, Multistage Passive and Active Delivery of Radiolabeled Nanogels for Superior Tumor Penetration Efficiency, Biomacromolecules, 18, 8, 2017. Crossref

  11. Kumar Krishan, Chawla Ruchi, Nanocarriers-mediated therapeutics as a promising approach for treatment and diagnosis of lung cancer, Journal of Drug Delivery Science and Technology, 65, 2021. Crossref

  12. Zhang Huihui, Cui Pengfei, Gao Zihan, Zhou Shuwen, Wang Cheng, Jiang Pengju, Ni Xinye, Wang Jianhao, Qiu Lin, A Facile Way To Improve the Bioavailability of Nanomedicine Based on the Threshold Theory, Molecular Pharmaceutics, 19, 5, 2022. Crossref

Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa Políticas de preços e assinaturas Begell House Contato Language English 中文 Русский Português German French Spain